Entegris to expand 3 life sciences manufacturing facilities
![](/46/pdcnewsitem/11/26/79/HLN00CPO_Entegris_990x525_scaled.jpg)
The expanded capacity and capabilities include the development of a dedicated Life Sciences Technology Center
Entegris will expand its manufacturing facilities located in Billerica, MA, Bloomington, MN, and Logan, UT as part of an approximately $30 million plan to invest in life sciences capacity and capabilities this year.
The facilities will develop and manufacture bioprocessing assemblies, such as the company's Aramus critical fluid handling product line currently used to produce and deliver vaccines worldwide.
Entegris has also started the development of its Life Sciences Technology Center located at its headquarters in Billerica, MA, which will provide application testing, process development, and solution demonstration services for bioprocess technologies including freeze, thaw, and filtration applications.
The announced expansions come as the pharmaceutical sector increases demand for high-purity systems designed for freezing, transporting, storing, and thawing drug substances, not just for COVID-19 vaccines, but also for oher treatments and therapeutics.
Bertrand Loy, Entegris’ President and CEO said the investment "further demonstrates the company's commitment to effectively serving this industry – now and in the future".
Better known for its operations in advanced materials science, Entegris considered itself a natural partner to the life sciences industry due to its expertise in complex manufacturing processes with their rigorous requirements for achieving high purity and high yields.
The company began developing solutions specific to bioprocessing needs before the COVID-19 pandemic.
More recently, it has used its capabilities in advanced manufacturing environments to provide key support to biopharmaceutical companies developing, producing and distributing vaccines.
![Entegris Inc.](https://www.cphi-online.com/c241592th_S-comp241592.jpg)
Related News
-
News CPHI Online Trend Report: what is pharmaceutical packaging really costing the industry?
The latest CPHI Online Trend Report dives into what it really costs to develop, manufacture, and deploy pharmaceutical packaging that balances sustainability concerns, patient safety, and drug efficacy. -
News Eli Lilly’s Alzheimer’s drug receives approval from US FDA
After facing several hurdles on its path to approval last year, Eli Lilly’s donanemab treatment for early Alzheimer’s, brand name Kisunla, received US FDA approval this past week. It is the second therapy for slowing the progression of Alzh... -
News This week in GLP-1 drug headlines: Manufacturing investment and new market launches
As drugmakers race to put their own GLP-1 drug products forward as the next biggest thing in weight-loss, current products are making numerous headlines this week with a number of new developments in their commercialisation and approval. Discover the l... -
News Women in Pharma: Regulating equity across regional borders
In our monthly series focusing on women in the pharmaceutical industry, we interview leading experts in the pharmaceutical supply and value chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Viral marketing for B2B pharma businesses: a CPHI Online case study
Discover how a Chinese chemical manufacturing company went viral on TikTok, and what their viral success means for the future of B2B digital marketing for the wider pharmaceutical industry and supply chain. -
News New Aurigene biologics facility opens in Hyderabad, India
Aurigene Pharmaceutical Services Ltd. have opened a biologics facility in Hyderabad, India in a biocluster known as Genome Valley. -
News Novo Nordisk launches 'Power of Wegovy' national campaign
Danish drugmaker Novo Nordisk have launched a new national campaign – The Power of Wegovy – that aims to educate those living with obesity on their blockbuster drug Wegovy throughout the United States. -
News Women in Pharma Anniversary: Celebrating Our Heroines of Pharma
Our Women in Pharma interview series is approaching its 1-year anniversary this month, and to celebrate, we are highlighting the Heroines of Pharma that our very own Women in Pharma admire.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance